Approximation to the Patient with Tumor of Unknown Origin
Journal Title: Journal of Integrative Oncology - Year 2017, Vol 6, Issue 2
Abstract
The tumor of unknown origin constitutes 3-7% of the cancers studied and is one of the 10 most frequent cancer diagnoses. It is a malignant tumor whose first origin or identification is not done in the clinical history, in the clinical exploration or in the complementary studies. At present, the effort in the primary search for the origin of the cancer that will be directed at specifying these entities and recognizing them as soon as possible is arduous. Today we have several techniques among which we highlight immunohistochemistry, molecular biology and radiodiagnosis that greatly facilitate the work of the clinician in detecting the origin of tumors, although none of them is conclusive.
Authors and Affiliations
Jesús Cobo Molinos, Antonio Cobo Molinos
A Red Skin Nodule
A 78-year-old woman presented with a 2-month-history of a cutaneous red nodule on her left leg (Figure 1). Differential diagnosis of nodular red lesions includes dermal nevus, pyogenic granuloma, angioma, amelanotic mela...
Reiki Therapy is Credible in Oncology. A Possible Analysis...
In an earlier article by the author, the effectiveness and efficacy of Reiki Therapy when used as complementary therapy in patients with blood cancer was demonstrated. With the present article, the author invites readers...
SIPA1 Gene Polymorphisms and the Risk of Breast Carcinoma among the Egyptian Females: A Pilot Study
Background: Multiple genes are known to influence the cancer metastasis but the effect of the germline heritable genetic polymorphisms on the predisposition and metastasis is not yet well known. Signal-induced proliferat...
Omega-3 Fatty Acids and Cancer Prevention
A recent review has summarized the evidence that omega-3 fatty acids (FA) have potential in reducing the risk for a common form of cancer [1]. This editorial is a synopsis of that review covering the historical interest...
Surveillance of Healthcare-Associated Infections Rates in Hematology-Oncology Patients
Background: Healthcare-associated infections (HAIs) consist of a major cause of morbidity and mortality among patients with hematologic malignancies, resulting in high length of stay and healthcare costs. The aim of this...